As the GLP-1 conversation evolves, Omada Health is updating its industry FAQs to deliver timely data and insights for virtual care buyers.
Our previous guides addressed new indications and their impact on employers and payers, as well as early outcomes of Omada’s Enhanced GLP-1 Care Track.
This guide addresses a reigning industry dilemma: though GLP-1 costs are declining, demand continues to rise. How can organizations manage the costs?
A popular industry solution has been to off-ramp patients as soon as possible to relieve payers of short-term prescription costs. However, recent data from Omada Insights Lab’s ANSWERS Initiative suggests that medication persistence, rather than early discontinuation, is key to GLP-1 cost containment and ROI.
Read on for the latest research on how Omada’s Enhanced GLP-1 Care Track can drive favorable health outcomes and decrease financial waste.
1 Care team assignments: Health coach - all cardiometabolic programs; Cardiometabolic specialist- Diabetes and Hypertension programs; Physical Therapist- Musculoskeletal program; Behavioral health specialist- all programs.
2 Exercise Specialists are assigned to members once they indicate via a standard PAR-Q assessment that it is safe to exercise.